Brown, Lisle/Cummings, Inc. Organon & Co. Call Options Transaction History
Brown, Lisle/Cummings, Inc.
- $329 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding OGN
# of Institutions
776Shares Held
190MCall Options Held
1.59MPut Options Held
931K-
Black Rock Inc. New York, NY32.6MShares$612 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA30.2MShares$567 Million0.01% of portfolio
-
Massachusetts Financial Services CO Boston, MA10.1MShares$190 Million0.07% of portfolio
-
State Street Corp Boston, MA9.01MShares$169 Million0.01% of portfolio
-
Nordea Investment Management Ab Stockholm, V77.43MShares$140 Million0.19% of portfolio
About Organon & Co.
- Ticker OGN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 254,330,000
- Market Cap $4.78B
- Description
- Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...